ALB and myocardial infarction: In the overall cohort, compared with new users of DPP4i, new users of GLP1a were more likely to have higher urine-to-albumin creatinine ratio levels, whereas new users of SGLT2i were more likely to have a history of myocardial infarction and higher eGFR levels.